BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32202612)

  • 1. Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials.
    Cudkowicz M; Chase MK; Coffey CS; Ecklund DJ; Thornell BJ; Lungu C; Mahoney K; Gutmann L; Shefner JM; Staley KJ; Bosch M; Foster E; Long JD; Bayman EO; Torner J; Yankey J; Peters R; Huff T; Conwit RA; ; Shinnar S; Patch D; Darras BT; Ellis A; Packer RJ; Marder KS; Chiriboga CA; Henchcliffe C; Moran JA; Nikolov B; Factor SA; Seeley C; Greenberg SM; Amato AA; DeGregorio S; Simuni T; Ward T; Kissel JT; Kolb SJ; Bartlett A; Quinn JF; Keith K; Levine SR; Gilles N; Coyle PK; Lamb J; Wolfe GI; Crumlish A; Mejico L; Iqbal MM; Bowen JD; Tongco C; Nabors LB; Bashir K; Benge M; McDonald CM; Henricson EK; Oskarsson B; Dobkin BH; Canamar C; Glauser TA; Woo D; Molloy A; Clark P; Vollmer TL; Stein AJ; Barohn RJ; Dimachkie MM; Le Pichon JB; Benatar MG; Steele J; Wechsler L; Clemens PR; Amity C; Holloway RG; Annis C; Goldberg MP; Andersen M; Iannaccone ST; Smith AG; Singleton JR; Doudova M; Haley EC; Quigg MS; Lowenhaupt S; Malow BA; Adkins K; Clifford DB; Teshome MA; Connolly N
    JAMA Neurol; 2020 Jun; 77(6):755-763. PubMed ID: 32202612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
    Wilcock D; Jicha G; Blacker D; Albert MS; D'Orazio LM; Elahi FM; Fornage M; Hinman JD; Knoefel J; Kramer J; Kryscio RJ; Lamar M; Moghekar A; Prestopnik J; Ringman JM; Rosenberg G; Sagare A; Satizabal CL; Schneider J; Seshadri S; Sur S; Tracy RP; Yasar S; Williams V; Singh H; Mazina L; Helmer KG; Corriveau RA; Schwab K; Kivisäkk P; Greenberg SM;
    Alzheimers Dement; 2021 Apr; 17(4):704-715. PubMed ID: 33480172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network for excellence in neuroscience clinical trials: NeuroNEXT.
    Natelson Love M; Fathallah-Shaykh H
    JAMA Neurol; 2013 Oct; 70(10):1227-8. PubMed ID: 23921561
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroscience networking: linking discovery to drugs.
    Heemskerk J; Farkas R; Kaufmann P
    Neuropsychopharmacology; 2012 Jan; 37(1):287-9. PubMed ID: 22157858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central institutional review board review for an academic trial network.
    Kaufmann P; O'Rourke PP
    Acad Med; 2015 Mar; 90(3):321-3. PubMed ID: 25406606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transitioning to the National Institutes of Health single institutional review board model: Piloting the use of the Streamlined, Multi-site, Accelerated Resources for Trials IRB Reliance.
    Vardeny O; Hernandez AF; Cohen LW; Franklin A; Baqai M; Palmer S; Bierer BE; Cobb N
    Clin Trials; 2019 Jun; 16(3):290-296. PubMed ID: 30866676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.
    Murphy P; Glynn D; Dias S; Hodgson R; Claxton L; Beresford L; Cooper K; Tappenden P; Ennis K; Grosso A; Wright K; Cantrell A; Stevenson M; Palmer S
    Health Technol Assess; 2021 Dec; 25(76):1-228. PubMed ID: 34990339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to institutional review board approval with local versus central review in a multicenter pragmatic trial.
    Neuman MD; Gaskins LJ; Ziolek T;
    Clin Trials; 2018 Feb; 15(1):107-111. PubMed ID: 28982261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Institute of Neurological Disorders and Stroke Common Data Element Project - approach and methods.
    Grinnon ST; Miller K; Marler JR; Lu Y; Stout A; Odenkirchen J; Kunitz S
    Clin Trials; 2012 Jun; 9(3):322-9. PubMed ID: 22371630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficiency of single institutional review board review in National Institute of Child Health and Human Development Cooperative Reproductive Medicine Network-initiated clinical trials.
    Diamond MP; Eisenberg E; Huang H; Coutifaris C; Legro RS; Hansen KR; Steiner AZ; Cedars M; Barnhart K; Ziolek T; Thomas TR; Maurer K; Krawetz SA; Wild RA; Trussell JC; Santoro N; Zhang H;
    Clin Trials; 2019 Feb; 16(1):3-10. PubMed ID: 30354458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Rare Diseases Clinical Research Network: a model for clinical trial readiness.
    Lumsden JM; Urv TK
    Ther Adv Rare Dis; 2023; 4():26330040231219272. PubMed ID: 38152157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NeuroNEXT: accelerating drug development in neurology.
    The Lancet Neurology
    Lancet Neurol; 2012 Feb; 11(2):119. PubMed ID: 22265207
    [No Abstract]   [Full Text] [Related]  

  • 16. Bridging the Gap in Neurotherapeutic Discovery and Development: The Role of the National Institute of Neurological Disorders and Stroke in Translational Neuroscience.
    Mott M; Koroshetz W
    Neurotherapeutics; 2015 Jul; 12(3):651-4. PubMed ID: 26081907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive summary: The Emergency Neurologic Clinical Trials Network meeting--a National Institute of Neurological Disorders and Stroke symposium.
    Pancioli AM; Barsan WG; Conwit RA
    Acad Emerg Med; 2004 Oct; 11(10):1092-6. PubMed ID: 15466154
    [No Abstract]   [Full Text] [Related]  

  • 18. Funding evidence: the National Institute of Neurological Disorders and Stroke Clinical Trials Program.
    Ravina B; Janis S; Keleti J; Marler JM
    NeuroRx; 2004 Jul; 1(3):317-22. PubMed ID: 15717033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing Events of Noncompliance in Neurology Human Subjects Research: the Effect of Human Subjects Research Protection Training and Site Initiation Visits.
    Gooden MJ; Norato G; Martin SB; Nath A; Reoma L
    Neurotherapeutics; 2021 Apr; 18(2):859-865. PubMed ID: 33475954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.